<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
   xmlns:content="http://purl.org/rss/1.0/modules/content/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:atom="http://www.w3.org/2005/Atom"
   xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
   xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
   xmlns:company="http://purl.org/rss/1.0/modules/company"
>
	<channel>
		<title>Latest News - Market Wire News</title>
		<atom:link href="https://marketwirenews.com/rss/news-releases/?s=derm" rel="self" type="application/rss+xml" />
		<link>https://marketwirenews.com</link>
		<description>Market Wire News RSS News Feed for Journey Medical Corporation (NASDAQ: DERM)</description>
		<lastBuildDate>Sat, 17 Oct 2026 05:56:11 -0400</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod> hourly </sy:updatePeriod>
		<sy:updateFrequency> 60 </sy:updateFrequency>

		<image>
			<url>https://marketwirenews.com/assets/img/icons/favicon-32x32.png</url>
			<title>Market Wire News</title>
			<link>https://marketwirenews.com</link>
			<width>32</width>
			<height>32</height>
		</image>
		<item>
            <title>Market Wire News Hottest Alerts Newsletter</title>
            <link>https://marketwirenews.com/newsletter/</link>
            <pubDate>Sat, 17 Oct 2026 05:56:11 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Subscribe to Market Wire News newsletter for instant real-time stock alerts, breaking financial news, trending stocks, and portfolio updates delivered to your email & mobile.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/newsletter/?v=3715</guid>
          </item>
          <item>
            <title>Market Wire News Trending Stocks</title>
            <link>https://marketwirenews.com/trending-stocks/</link>
            <pubDate>Sat, 17 Oct 2026 05:56:11 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Stock Picks]]></category>
            <category><![CDATA[Stock ALerts]]></category>
            <description><![CDATA[Track today's hottest trending stocks on NASDAQ, NYSE, OTCMKTS & Canadian markets. See massive % gainers, real-time movers, volumes, and linked breaking news updates.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/trending-stocks/?v=3715</guid>
          </item>
          <item>
            <title>Market Wire News Investor Awarenewss</title>
            <link>https://marketwirenews.com/advertise/</link>
            <pubDate>Sat, 17 Oct 2026 05:56:11 -0400</pubDate>
            <dc:creator><![CDATA[Market Wire News]]></dc:creator>
            <category><![CDATA[Invesor Awareness]]></category>
            <category><![CDATA[Investor Releatios]]></category>
            <description><![CDATA[Stock Promoter, Investor Relations, Investor Awareness, Market Wire News, investor brand advertisement services, plans and pricing.]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/advertise/?v=3715</guid>
          </item>
		<item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews May 19, 2026 04:45:00 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-a-g-p--6521397937770482.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 19 May 2026 16:45:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical,&#x201D; &#x201C;the Company,&#x201D; &#x201C;we&#x201D; or &#x201C;our&#x201D;), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-appr...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-a-g-p--6521397937770482.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews May 13, 2026 04:01:00 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-first-quarter-20-5854239342323743.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 13 May 2026 16:01:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million&#xA0;     Emrosi  &#xAE;   revenues were $6.3 million in the first quarter ended March 31, 2026     Cash position increased to $27 million, driven by strong financial performance     Company to...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-first-quarter-20-5854239342323743.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews May 06, 2026 04:01:00 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-first-quarte-6442330125869262.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 06 May 2026 16:01:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., May 06, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on developing, selling and marketing U.S. Food and Drug Administration (&#x2...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-first-quarte-6442330125869262.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews April 21, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-secures-contract-with-th-6807845665222405.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 21 Apr 2026 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., April 21, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical&#x201D; or &#x201C;the Company&#x201D;, &#x201C;we&#x201D;, or &#x201C;our&#x201D;), a commercial-stage pharmaceutical company primarily focused on developing, selling and mar...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-secures-contract-with-th-6807845665222405.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 25, 2026 04:01:00 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-full-year-2025-f-8273423913929140.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 25 Mar 2026 16:01:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024     Emrosi  &#x2122;  &#xA0;generated net revenues of $14.7 million during the full-year period after its launch in early April 2025     Approximately 53,000 total prescriptions were filled for Emrosi&#x2122;  &#xA0;d...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-full-year-2025-f-8273423913929140.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 18, 2026 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-year-end-202-4713709648241969.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 18 Mar 2026 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., March 18, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA&#x...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-year-end-202-4713709648241969.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews December 10, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-publication-of-6596573495186542.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 10 Dec 2025 08:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Clinical trial achieved all three primary objectives with no significant safety issues being reported         Results indicate that Emrosi can be safely used for up to 16 weeks with no detectable impact on skin, GI tract or vaginal microbiota         FDA-approved Emrosi (40 mg Minocycline Hydroch...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-publication-of-6596573495186542.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews November 12, 2025 04:01:00 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-third-quarter-20-5936857490944620.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 12 Nov 2025 16:01:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Third     quarter 2025 net revenues were     $17.6     million         Emrosi&#x2122; total prescriptions increased 146% over the second quarter of 2025         Emrosi net revenues were $4.9 million         Company to hold conference call today at 4:30 p.m. ET to discuss the financial results and...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-third-quarter-20-5936857490944620.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews November 05, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-third-quarte-4592325518338305.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 05 Nov 2025 08:30:00 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA&#x2...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-third-quarte-4592325518338305.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews October 24, 2025 08:30:18 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-combined-emrosi--4832772099039430.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 24 Oct 2025 08:30:18 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory lesions of rosacea in adults         DFD-29 demonstrated superior efficacy in IGA success rates a...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-combined-emrosi--4832772099039430.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews October 08, 2025 08:30:32 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-octobe-5910563042097403.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 08 Oct 2025 08:30:32 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or &#x201C;the Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA&#x2...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-octobe-5910563042097403.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews September 03, 2025 08:30:57 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-septem-6244072302450372.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 03 Sep 2025 08:30:57 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or &#x201C;the Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA&#x...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-septem-6244072302450372.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews August 12, 2025 04:01:21 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-second-quarter-2-6944267262693833.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 12 Aug 2025 16:01:21 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[S     econd quarter 2025 revenues were     $15.0     million         Emrosi&#x2122; net sales of $2.8 million generated in first full quarter on the market         The Company joined the Russell 2000&#xAE; and Russell 3000&#xAE; Indexes in June 2025           Company to hold conference call today...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-second-quarter-2-6944267262693833.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews August 07, 2025 08:30:01 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-ring-nasdaq-stock-mar-8925670191929548.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 07 Aug 2025 08:30:01 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical&#x201D; or &#x201C;the Company&#x201D;, &#x201C;we&#x201D;, or &#x201C;our&#x201D;), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-ring-nasdaq-stock-mar-8925670191929548.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews August 05, 2025 04:01:19 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-second-quart-8830657553922573.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 05 Aug 2025 16:01:19 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (&#x201C;FD...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-second-quart-8830657553922573.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews July 14, 2025 08:30:07 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-expanded-payer-7292549931547028.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 14 Jul 2025 08:30:07 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Payer coverage for Emrosi&#x2122; now available for 65% of commercial lives, up from 29% in May 2025         Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase       SCOTTSDALE, Ariz., July 14, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-expanded-payer-7292549931547028.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews June 24, 2025 08:30:29 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-to-join-russell-2000-xae-and-russell-5652487307767952.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 24 Jun 2025 08:30:29 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., June 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;, &#x201C;we&#x201D;, or &#x201C;our&#x201D;), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-to-join-russell-2000-xae-and-russell-5652487307767952.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews June 20, 2025 08:30:33 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-emrosi-tm-data-8736619856097361.html?utm_source=rss-news-releases</link>
            <pubDate>Fri, 20 Jun 2025 08:30:33 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., June 20, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical&#x201D; or &#x201C;the Company&#x201D;, &#x201C;we&#x201D;, or &#x201C;our&#x201D;), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-emrosi-tm-data-8736619856097361.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews June 09, 2025 08:30:01 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-emrosi-tm-feat-5170771082070301.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 09 Jun 2025 08:30:01 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[National TV Segment Highlights FDA-Approved Treatment for Rosacea         Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET       SCOTTSDALE, Ariz., June 09, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Me...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-emrosi-tm-feat-5170771082070301.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews May 15, 2025 04:05:12 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/fortress-biotech-reports-first-quarter-2025-financia-8912915291233675.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 15 May 2025 16:05:12 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Emrosi&#x2122; commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults         Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; special meeting of Checkpoint stockholders to approve the transaction to take place on May 28, 2025         F...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/fortress-biotech-reports-first-quarter-2025-financia-8912915291233675.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews May 14, 2025 04:01:35 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-first-quarter-20-7882138413946064.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 14 May 2025 16:01:35 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Revenue     for the First Quarter Ended March 31, 2025     was     $13.1     million         Emrosi&#x2122; (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025         Phase 3 Clinical Trial Results f...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-first-quarter-20-7882138413946064.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews May 07, 2025 04:01:25 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-first-quarte-5583338757550510.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 07 May 2025 16:01:25 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-first-quarte-5583338757550510.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews April 01, 2025 04:01:16 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-appoints-ramsey-alloush--7524608880355240.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 01 Apr 2025 16:01:16 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., April 01, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (&#...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-appoints-ramsey-alloush--7524608880355240.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 26, 2025 04:01:00 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-full-year-2024-f-8094495490403846.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 26 Mar 2025 16:01:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[FDA Approval of Emrosi&#x2122; (   40 mg Minocycline Hydrochloride Modified-Release Capsules   ) for Rosacea         Emrosi Initial Distribution Ongoing; First Prescriptions Filled         Total     Revenues     for the Full Year Ended December 31, 2024     were     $56.1     million         Met ...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-reports-full-year-2024-f-8094495490403846.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 24, 2025 08:30:00 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-launches-emrosi-tm-40-mg-4873766937409132.html?utm_source=rss-news-releases</link>
            <pubDate>Mon, 24 Mar 2025 08:30:00 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[Initial distribution of Emrosi to pharmacies ongoing         First prescriptions of Emrosi filled       SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical&#x201D;), a commercial-stage pharmaceutical company that primarily focu...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-launches-emrosi-tm-40-mg-4873766937409132.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 19, 2025 04:01:56 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-year-end-202-6789711920990852.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 19 Mar 2025 16:01:56 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., March 19, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D; or the &#x201C;Company&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (&#x201C;F...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-announce-year-end-202-6789711920990852.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 12, 2025 08:30:49 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-the-37-8464563957909401.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 12 Mar 2025 08:30:49 -0400</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., March 12, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (&#x201C;Journey Medical&#x201D;) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA&#x201D;)-approved prescripti...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-participate-in-the-37-8464563957909401.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 05, 2025 04:01:06 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-publication-in-6046477273928597.html?utm_source=rss-news-releases</link>
            <pubDate>Wed, 05 Mar 2025 16:01:06 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[DFD-29 (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) achieved the co-primary and all secondary endpoints with no significant safety issues when administered once daily for 16 weeks         Published data from two Phase 3 clinical t...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-announces-publication-in-6046477273928597.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews March 04, 2025 04:01:50 pm</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-exhibit-at-the-2025-a-4832818662379573.html?utm_source=rss-news-releases</link>
            <pubDate>Tue, 04 Mar 2025 16:01:50 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., March 04, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical&#x201D;), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA&#x201D;)-approved prescripti...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-exhibit-at-the-2025-a-4832818662379573.html?s=derm?v=<?php echo 3715;?></guid>
            </item><item>
            <title>$DERM Journey Medical Corporation #MWN #BreakingNews January 23, 2025 08:30:42 am</title>
            <link>https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-host-conference-call--5920805524511062.html?utm_source=rss-news-releases</link>
            <pubDate>Thu, 23 Jan 2025 08:30:42 -0500</pubDate>
            <dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
            <category><![CDATA[DERM]]></category>
            <category><![CDATA[Journey Medical Corporation]]></category>
            <description><![CDATA[SCOTTSDALE, Ariz., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (&#x201C;Journey Medical&#x201D;), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (&#x201C;FDA&#x201D;)-approved prescriptio...]]></description>
            <guid isPermaLink="false">https://marketwirenews.com/stock/derm/news/journey-medical-corporation-to-host-conference-call--5920805524511062.html?s=derm?v=<?php echo 3715;?></guid>
            </item>
	</channel>
</rss>